AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31855102 — intervention group
Group type: COMPARATOR
Intervention: Psychometric approaches (triangulation) used to suggest responder thresholds for EHP-30 domains.
Number of subjects: 1686
Study 31402449 — intervention group
Group type: EXPERIMENTAL
Intervention: Transmuscular quadratus lumborum block
Number of subjects: 82
Study 31402449 — intervention group
Group type: COMPARATOR
Intervention: Pre-peritoneal catheter block
Number of subjects: 82
Study 27796574 — intervention group
Group type: EXPERIMENTAL
Intervention: Screw-retained crowns (n=53)
Number of subjects: 58
Study 27796574 — intervention group
Group type: COMPARATOR
Intervention: Cemented crowns (n=61)
Number of subjects: 58
Study 25501016 — intervention group
Group type: EXPERIMENTAL
Intervention: Gd-DTPA (single bolus)
Number of subjects: 10
Study 25501016 — intervention group
Group type: EXPERIMENTAL
Intervention: Gd-DTPA (dual bolus)
Number of subjects: 10
Study 25501016 — intervention group
Group type: EXPERIMENTAL
Intervention: Gd-DTPA (nonlinear correction)
Number of subjects: 10
Study 25501016 — intervention group
Group type: EXPERIMENTAL
Intervention: Gd-BOPTA (dual bolus)
Number of subjects: 10
Study 25501016 — intervention group
Group type: EXPERIMENTAL
Intervention: Gd-BOPTA (single bolus)
Number of subjects: 10
Study 25501016 — intervention group
Group type: EXPERIMENTAL
Intervention: Gd-BOPTA (nonlinear correction)
Number of subjects: 10
Study 25501016 — intervention group
Group type: COMPARATOR
Intervention: Gd-BOPTA
Number of subjects: 10
Study 24220352 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir added to syndromic management
Number of subjects: 422
Study 24220352 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrent HSV-2
Number of subjects: 422
Study 24220352 — intervention group
Group type: COMPARATOR
Intervention: No specific control group mentioned
Number of subjects: 422
Study 20726843 — intervention group
Group type: EXPERIMENTAL
Intervention: D-dimer levels
Number of subjects: 382
Study 20026818 — intervention group
Group type: EXPERIMENTAL
Intervention: Current intensity-modulated radiation therapy (IMRT) protocol using the Pinnacle(3) planning system
Number of subjects: 104
Study 20026818 — intervention group
Group type: COMPARATOR
Intervention: Conventional lateral opposing-field radiation or initial IMRT protocol using the Best nomos PEACOCK planning system
Number of subjects: 104
Study 16950654 — intervention group
Group type: EXPERIMENTAL
Intervention: Email-delivered, pedometer-based intervention with TTM strategies
Number of subjects: 74
Study 16950654 — intervention group
Group type: COMPARATOR
Intervention: Email-delivered, pedometer-based intervention without TTM strategies
Number of subjects: 74
Study 15083241 — intervention group
Group type: EXPERIMENTAL
Intervention: Demand feeding
Number of subjects: 11
Study 15083241 — intervention group
Group type: COMPARATOR
Intervention: Scheduled feeding
Number of subjects: 11
Study 12023504 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress reduction interventions (not specified if alone or in combination with pharmacotherapies targeting the HPA axis)
Number of subjects: 0
Study 12023504 — intervention group
Group type: EXPERIMENTAL
Intervention: Drugs affecting the synthesis and/or secretion of corticosterone
Number of subjects: 0
Study 12023504 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosterone increase
Number of subjects: 0
Study 12023504 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticotropin-releasing hormone (CRH)
Number of subjects: 0
Study 12023504 — intervention group
Group type: EXPERIMENTAL
Intervention: Stressors or cocaine-associated cues during abstinence
Number of subjects: 0
Study 10463960 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 400 mg twice daily for two weeks
Number of subjects: 44
Study 10463960 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 7751683 — intervention group
Group type: EXPERIMENTAL
Intervention: OPV containing twice the standard potency of Sabin type 1 virus
Number of subjects: 1409
Study 7751683 — intervention group
Group type: COMPARATOR
Intervention: Standard formulations of OPV
Number of subjects: 1409
Study 2261610 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine
Number of subjects: 30
Study 2261610 — intervention group
Group type: COMPARATOR
Intervention: Fluoride
Number of subjects: 30
Study 2261610 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 555487 — intervention group
Group type: EXPERIMENTAL
Intervention: Special behavior therapy group
Number of subjects: 0
Study 555487 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular behavior therapy group
Number of subjects: 0
Study 555487 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy group
Number of subjects: 0
Study 6362465 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 6362465 — intervention group
Group type: COMPARATOR
Intervention: Low dose of alcohol
Number of subjects: 24
Study 6362465 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of alcohol
Number of subjects: 24
Study 29702033 — intervention group
Group type: EXPERIMENTAL
Intervention: Video biography
Number of subjects: 523
Study 29702033 — intervention group
Group type: EXPERIMENTAL
Intervention: Video with b-roll biography
Number of subjects: 523
Study 29702033 — intervention group
Group type: COMPARATOR
Intervention: Text-only biography
Number of subjects: 523
Study 29702033 — intervention group
Group type: EXPERIMENTAL
Intervention: Video biography (a-roll only)
Number of subjects: 523
Study 29702033 — intervention group
Group type: EXPERIMENTAL
Intervention: Video including added b-roll
Number of subjects: 523
Study 27533472 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral rehydration solution (500 mL) before abdominal and pelvic CT; n = 2244 patients.
Number of subjects: 5959
Study 27533472 — intervention group
Group type: COMPARATOR
Intervention: Control group (no rehydration); n = 2244 patients (adjusted control group).
Number of subjects: 5959
Study 27533472 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclinically dehydrated group; n = 997 patients.
Number of subjects: 5959
Study 27533472 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrated group; n = 4962 patients.
Number of subjects: 5959
Study 25631723 — intervention group
Group type: EXPERIMENTAL
Intervention: NaOCl 2.5%
Number of subjects: 40
Study 25631723 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopure MTAD™
Number of subjects: 40
Study 25631723 — intervention group
Group type: COMPARATOR
Intervention: 0.9% Saline (Control)
Number of subjects: 40
Study 23195668 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproic acid (VPA)
Number of subjects: 0
Study 23195668 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 20919574 — intervention group
Group type: EXPERIMENTAL
Intervention: Reamberin (400 ml/day for 10 days)
Number of subjects: 427
Study 18842392 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg of isoflavone
Number of subjects: 47
Study 18842392 — intervention group
Group type: COMPARATOR
Intervention: 40 mg of casein placebo
Number of subjects: 47
Study 16103382 — intervention group
Group type: EXPERIMENTAL
Intervention: P6 acupressure
Number of subjects: 60
Study 16103382 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo acupressure
Number of subjects: 60
Study 16103382 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 12050246 — intervention group
Group type: EXPERIMENTAL
Intervention: GH treatment (2 IU/m(2).d)
Number of subjects: 25
Study 10332942 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-s breathhold while supine
Number of subjects: 12
Study 10332942 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-s breathhold while standing
Number of subjects: 12
Study 10332942 — intervention group
Group type: COMPARATOR
Intervention: Comparison of supine vs standing during breathhold
Number of subjects: 12
Study 7483152 — intervention group
Group type: EXPERIMENTAL
Intervention: New treatment
Number of subjects: 0
Study 2031520 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin, 400 mg twice daily for 10 days
Number of subjects: 38
Study 2031520 — intervention group
Group type: COMPARATOR
Intervention: Cefoxitin, 2 gm intramuscular plus probenecid, 1 gm, followed by doxycycline, 100 mg twice daily for 10 days
Number of subjects: 38
Study 6759242 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 16
Study 6759242 — intervention group
Group type: COMPARATOR
Intervention: Multiple subcutaneous injections (MSI)
Number of subjects: 16
Study 6759242 — intervention group
Group type: COMPARATOR
Intervention: Both CSII and MSI
Number of subjects: 16
Study 31552584 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone 20 mg per day for 14 days
Number of subjects: 53
Study 31552584 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone once daily for 14 days
Number of subjects: 53
Study 30892477 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperinflation with mechanical ventilator + vibrocompression
Number of subjects: 93
Study 30892477 — intervention group
Group type: COMPARATOR
Intervention: Tracheal aspiration alone
Number of subjects: 93
Study 28068938 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with methylcobalamin (Met + Acu)
Number of subjects: 104
Study 28068938 — intervention group
Group type: COMPARATOR
Intervention: Methylcobalamin alone
Number of subjects: 104
Study 27255280 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness audios
Number of subjects: 90
Study 27255280 — intervention group
Group type: COMPARATOR
Intervention: Audios of readings from a non-fiction book
Number of subjects: 90
Study 25127178 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused Exposure Therapy (EXP)
Number of subjects: 120
Study 25127178 — intervention group
Group type: COMPARATOR
Intervention: Health & Lifestyles (HLS)
Number of subjects: 120
Study 22559092 — intervention group
Group type: EXPERIMENTAL
Intervention: MSB‐Nutrition program
Number of subjects: 320
Study 22559092 — intervention group
Group type: COMPARATOR
Intervention: On‐campus weight management course
Number of subjects: 320
Study 22559092 — intervention group
Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 320
Study 19243606 — intervention group
Group type: EXPERIMENTAL
Intervention: KAb201 via intra-arterial route at 50 mCi
Number of subjects: 25
Study 19243606 — intervention group
Group type: COMPARATOR
Intervention: KAb201 via intravenous route at 50 mCi
Number of subjects: 25
Study 19243606 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall response rate
Number of subjects: 25
Study 19243606 — intervention group
Group type: EXPERIMENTAL
Intervention: Median overall survival
Number of subjects: 25
Study 17113309 — intervention group
Group type: EXPERIMENTAL
Intervention: Intentional movements to produce an effect (tone) with a success ratio of 2:1
Number of subjects: 0
Study 17113309 — intervention group
Group type: COMPARATOR
Intervention: Removal of intentional attribution of the effect
Number of subjects: 0
Study 15196110 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 3 mg
Number of subjects: 495
Study 15196110 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol 1.25 mg
Number of subjects: 495
Study 15196110 — intervention group
Group type: COMPARATOR
Intervention: No prophylactic antiemetic
Number of subjects: 495
Study 11485528 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic dissector
Number of subjects: 132
Study 9669465 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilization appliance
Number of subjects: 60
Study 9669465 — intervention group
Group type: COMPARATOR
Intervention: Control appliance
Number of subjects: 60
Study 7838618 — intervention group
Group type: EXPERIMENTAL
Intervention: He‐O2 mixture (20.9% O2/79.1% He)
Number of subjects: 11
Study 7838618 — intervention group
Group type: COMPARATOR
Intervention: Air
Number of subjects: 11
Study 3362274 — intervention group
Group type: EXPERIMENTAL
Intervention: sulindac 200 mg p.o. b.i.d.
Number of subjects: 74
Study 3362274 — intervention group
Group type: COMPARATOR
Intervention: indomethacin 25 mg p.o. t.i.d. and 100 mg p.r.
Number of subjects: 74
Study 31149841 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervicothoracic transcutaneous electrical nerve stimulation (CTENS) - 30 min twice daily, 80-Hz frequency, 150-μs pulse duration for 14 days
Number of subjects: 17
Study 31149841 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervicothoracic transcutaneous electrical nerve stimulation (CTENS)
Number of subjects: 17
Study 31149841 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 17
Study 28786995 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated case conferencing (FCC)
Number of subjects: 286
Study 28786995 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 286
Study 25795959 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine
Number of subjects: 10
Study 25795959 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 22861816 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional electrical stimulation (FES) with balance training for two weeks
Number of subjects: 21
Study 22861816 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance training alone for two weeks
Number of subjects: 21
Study 22861816 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 21
Study 21859765 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 20
Study 21859765 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 19124524 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept plus methotrexate
Number of subjects: 0
Study 19124524 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate alone
Number of subjects: 0
Study 16415316 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS 40-50, effect site remifentanil concentration 1 ng ml(‐1)
Number of subjects: 95
Study 16415316 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS 40-50, remifentanil 2 ng ml(‐1)
Number of subjects: 95
Study 16415316 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS 40-50, remifentanil 4 ng ml(‐1)
Number of subjects: 95
Study 16415316 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS 25-35, remifentanil 2 ng ml(‐1)
Number of subjects: 95
Study 16415316 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS 55-65, remifentanil 2 ng ml(‐1)
Number of subjects: 95
Study 16415316 — intervention group
Group type: EXPERIMENTAL
Intervention: PPG variation in responders
Number of subjects: 95
Study 16415316 — intervention group
Group type: EXPERIMENTAL
Intervention: PPG variation
Number of subjects: 95
Study 15553107 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg intravenous orphenadrine citrate
Number of subjects: 18
Study 15553107 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 11568514 — intervention group
Group type: COMPARATOR
Intervention: 20 mg/1.73 m2
Number of subjects: 9
Study 11568514 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/1.73 m2
Number of subjects: 9
Study 9333107 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 20 mg/day for 28 days
Number of subjects: 44
Study 9333107 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin 20 mg/day for 28 days
Number of subjects: 44
Study 9333107 — intervention group
Group type: COMPARATOR
Intervention: Coadministration of pravastatin or lovastatin with cyclosporine
Number of subjects: 44
Study 9333107 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin and lovastatin
Number of subjects: 44
Study 8408451 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (1.5 mg) pretreatment
Number of subjects: 2
Study 8408451 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol treatment (0.05 mg/kg, i.v.)
Number of subjects: 2
Study 8408451 — intervention group
Group type: COMPARATOR
Intervention: Placebo pretreatment
Number of subjects: 2
Study 3936774 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon dioxide laser
Number of subjects: 43
Study 3936774 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 43
Study 31651335 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapael Smart Board™ (SB) with 30 min of intervention and 30 min of standard occupational therapy
Number of subjects: 26
Study 31651335 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapael Smart Board™ (SB)
Number of subjects: 26
Study 31651335 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON) with 60 min of conventional occupational therapy
Number of subjects: 26
Study 29084736 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (45 mg/d target dose)
Number of subjects: 3876
Study 29084736 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3876
Study 24986061 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with CoQ (Med + CoQ diet)
Number of subjects: 10
Study 24986061 — intervention group
Group type: COMPARATOR
Intervention: Saturated fat diet
Number of subjects: 10
Study 24986061 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean diet
Number of subjects: 10
Study 24986061 — intervention group
Group type: COMPARATOR
Intervention: Low-fat, high-carbohydrate diet enriched in n-3 polyunsaturated fat
Number of subjects: 10
Study 23857856 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-ratio (1:1:1) transfusion protocol
Number of subjects: 78
Study 23857856 — intervention group
Group type: COMPARATOR
Intervention: Laboratory-results-guided transfusion protocol (control)
Number of subjects: 78
Study 23857856 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 78
Study 21338804 — intervention group
Group type: EXPERIMENTAL
Intervention: High energy diet (OVR) - 1.62 Mcal of NE<sub>L</sub>/kg; 15% crude protein, ad libitum intake
Number of subjects: 47
Study 21338804 — intervention group
Group type: COMPARATOR
Intervention: Control diet (CON) - 1.21 Mcal of NE<sub>L</sub>/kg; 14.2% crude protein, 100% NRC requirements
Number of subjects: 47
Study 21338804 — intervention group
Group type: COMPARATOR
Intervention: Restricted intake diet (RES) - 1.62 Mcal of NE<sub>L</sub>/kg; 15% crude protein, 80% of energy requirements
Number of subjects: 47
Study 19379491 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time perfusion contrast echocardiography using angiomode (AM)
Number of subjects: 50
Study 19379491 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time perfusion contrast echocardiography using high-resolution grayscale (HR)
Number of subjects: 50
Study 19379491 — intervention group
Group type: COMPARATOR
Intervention: SPECT
Number of subjects: 50
Study 17678780 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral near-infrared spectroscopy (NIRS)
Number of subjects: 35
Study 15006949 — intervention group
Group type: EXPERIMENTAL
Intervention: Eucapnic voluntary hyperventilation (EVH) for 6 min inhaling dry air containing 5% carbon dioxide at a target ventilation of 30 times baseline FEV(1)
Number of subjects: 38
Study 15006949 — intervention group
Group type: COMPARATOR
Intervention: Field exercise (cross-country skiing, ice skating, or running for 6 to 8 min)
Number of subjects: 38
Study 15006949 — intervention group
Group type: EXPERIMENTAL
Intervention: Eucapnic voluntary hyperventilation (EVH)
Number of subjects: 38
Study 11793265 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal Nasal Dilator (Nasanita)
Number of subjects: 0
Study 7756941 — intervention group
Group type: EXPERIMENTAL
Intervention: Biokit ELISA
Number of subjects: 8
Study 7756941 — intervention group
Group type: COMPARATOR
Intervention: Murex assay
Number of subjects: 8
Study 2837033 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytobrush
Number of subjects: 200
Study 2837033 — intervention group
Group type: COMPARATOR
Intervention: Cotton swab
Number of subjects: 200
Study 2837033 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytobrush and Cotton swab
Number of subjects: 200
Study 31668138 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour-change intervention for physical activity (PA)
Number of subjects: 60
Study 31668138 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60
Study 31276810 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient specialist palliative care consultations and outpatient phone follow-up by a palliative care nurse
Number of subjects: 63
Study 31276810 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 63
Study 29102440 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioguided Occult Lesion Localisation using Iodine‐125 Seed (ROLLIS)
Number of subjects: 218
Study 29102440 — intervention group
Group type: COMPARATOR
Intervention: Conventional Hookwire Localisation (HWL)
Number of subjects: 218
Study 29102440 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple localisation devices
Number of subjects: 218
Study 25794531 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste with 1100 ppm F supplemented with 3% TMP
Number of subjects: 84
Study 25794531 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste with 1100 ppm F
Number of subjects: 84
Study 25794531 — intervention group
Group type: COMPARATOR
Intervention: Toothpaste without F and TMP (placebo)
Number of subjects: 84
Study 25794531 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste with 1100 ppm F supplemented with 1% TMP
Number of subjects: 84
Study 25794531 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste with 1100 ppm F supplemented with 4.5% TMP
Number of subjects: 84
Study 25794531 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste with 1100 ppm F supplemented with 6% TMP
Number of subjects: 84
Study 25794531 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste with 1100 ppm F supplemented with 9% TMP
Number of subjects: 84
Study 23736111 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise training (PHRT)
Number of subjects: 43
Study 21477503 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal barriers to walking and physical activity
Number of subjects: 75
Study 21477503 — intervention group
Group type: EXPERIMENTAL
Intervention: Built-environment barriers to walking and physical activity
Number of subjects: 75
Study 21477503 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitators to walking
Number of subjects: 75
Study 21477503 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-related quality of life
Number of subjects: 75
Study 21477503 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health quality of life
Number of subjects: 75